TransMedics (TMDX) Share-based Compensation (2018 - 2026)

TransMedics has reported Share-based Compensation for 9 years, with the latest figure at $54.4 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 480.45% year-over-year to $54.4 million in Q2 2026; TTM through Jun 2026 was $54.4 million, a 46.86% increase from a year earlier, with the FY2025 full-year figure at $63.1 million, up 15.57% from the prior year.
• Share-based Compensation was $54.4 million for Q2 2026 at TransMedics, down from $59.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $67.5 million in Q3 2025, with the low at $2.3 million in Q1 2022.
• Average Share-based Compensation over 5 years is $15.1 million, with a median of $7.3 million recorded in 2024.
• The largest YoY upside for Share-based Compensation was 749.7% in 2025 against a maximum downside of 12.74% in 2025.
• Over 5 years, Share-based Compensation stood at $3.0 million in 2022, then soared by 91.37% to $5.7 million in 2023, then soared by 88.1% to $10.8 million in 2024, then retreated by 12.74% to $9.4 million in 2025, then jumped by 479.03% to $54.4 million in 2026.
• The last three Share-based Compensation figures came in at $54.4 million (Q2 2026), $59.1 million (Q1 2026), and $9.4 million (Q4 2025), per Business Quant data.